Arginine Depletion in Human Cancers

• Published in: Cancers Vol. 13; no. 24; p. 6274
• Main Authors: Nelakurti, Devi D, Rossetti, Tiffany, Husbands, Aman Y, Petreaca, Ruben C
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 14.12.2021; MDPI
• Subjects: Amino acid substitution; Amino acids; Arginine; Bias; Cancer; Cell cycle; Codons; Cysteine; Datasets; Evolution; Fibroblast growth factor receptors; Gene expression; Genomes; Glutamine; Histidine; Mutation; Proteins; purifying selection; Signal transduction; Tryptophan; mutation; purifying selection; cancer; arginine
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers13246274

Arginine is encoded by six different codons. Base pair changes in any of these codons can have a broad spectrum of effects including substitutions to twelve different amino acids, eighteen synonymous changes, and two stop codons. Four amino acids (histidine, cysteine, glutamine, and tryptophan) account for over 75% of amino acid substitutions of arginine. This suggests that a mutational bias, or "purifying selection", mechanism is at work. This bias appears to be driven by C > T and G > A transitions in four of the six arginine codons, a signature that is universal and independent of cancer tissue of origin or histology. Here, we provide a review of the available literature and reanalyze publicly available data from the Catalogue of Somatic Mutations in Cancer (COSMIC). Our analysis identifies several genes with an arginine substitution bias. These include known factors such as IDH1, as well as previously unreported genes, including four cancer driver genes (FGFR3, PPP6C, MAX, GNAQ). We propose that base pair substitution bias and amino acid physiology both play a role in purifying selection. This model may explain the documented arginine substitution bias in cancers.